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Abstract 
Psoriatic arthritis (PsA), a chronic systemic inflammatory disorder, impairs 
the quality of life of patients. The aim of this study was to describe the 
medical resource use in patients with PsA in a comprehensive 
rheumatological center in Colombia. We retrospectively analyzed patients 
diagnosed with PsA who were attended in a center of excellence for 
rheumatic diseases located in Bogotá, D.C. Colombia, from January to 
December 2019. A database of medical records was analyzed to identify the 
use of medical resources classified by specialized physician visits, 
medications and ambulatory services (e.g., diagnostic, laboratory or image 
procedures, physical therapy). We reported absolute and relative frequencies 
among diagnostic groups. This study had no risk for patients. Ninety-six 
patients with PsA were studied, 57% were women. The mean age was 58.08 
(±12.3 years), 90.63% of diagnostic was arthropathic psoriasis, other 
diagnostics were rheumatoid arthritis without rheumatoid factor, 
unspecified site (2.08%) and psoriasis, unspecified (2.08%) (ICD-10 code 
L405, M060, L409, respectively). In terms of treatments, most of the 
patients used a conventional disease-modifying antirheumatic drugs 
(DMARDs), methotrexate was the most frequent (represented the 14% of 
prescription and 78% of patients). On the other hand, 56.25% of patients 
receive treatment with biological DMARDs (10% of prescription). Among 
these biologicals, adalimumab (17.71%) and secukinumab (16.67%) were the 
most used. Regarding other health services, the visit to the specialist and the 
RX were the most common (83.33% of patients). Chest RX and column RX 
(17.71% each) had the highest frequency. This is one of the first approaches 
to the estimation of use of medical resources of PsA in Colombia. Frequency 
of DMARS use was associated to the severity and medical control of patients. 
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